Bloomios, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BLMS research report →
Price Chart
About the company
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company’s product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats.
- CEO
- Michael Hill
- IPO
- 2003
- Employees
- 23
- HQ
- Santa Barbara, CA, US
Get TickerSpark's AI analysis on BLMS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $19.34K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -1.82
- Div Yield
- 0.00%
- Gross Margin
- 36.66%
- Op Margin
- -68.13%
- Net Margin
- -226.66%
- ROE
- 953.05%
- ROIC
- -19.57%
Latest fiscal year · YoY change
- Revenue
- $6.08M-28.4%
- Gross Profit
- $2.23M-41.1%
- Op Income
- $-4,140,000
- Net Income
- $-13,774,000-584.9%
- EPS
- $-1.04-550.0%
- OCF Growth
- -6320.8%
- FCF Growth
- -608.1%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.43
- RSI (14)
- 100
- Avg Volume
- 3
No earnings-call transcripts are available for BLMS yet.
- Free Float
- 65.5%
- Shares Outstanding
- 64.47M
- Float Shares
- 42.23M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 22, 22 | Rohrer Douglas S | other | 550,000 |
| Nov 22, 22 | Rohrer Douglas S | other | 0 |
| Dec 15, 21 | EMC2 Capital LLC | other | 0 |
| Jul 9, 21 | daprile bibi | other | 0 |
| Jul 9, 21 | daprile bibi | other | 95 |
| Jul 9, 21 | elkayam aline hayuta | other | 0 |
| Jul 9, 21 | elkayam aline hayuta | other | 95 |
| Jul 9, 21 | HILL MICHAEL | other | 1,263,125 |
| Jul 9, 21 | HILL MICHAEL | other | 5,000 |
| Jul 9, 21 | HILL MICHAEL | other | 86 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BLMS coverage
Recent articles, reports, and earnings notes.
No research on BLMS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BLMS report →Bloomios Reports Q2 2023 Financial Results
prismmediawire.com · Aug 30
Bloomios To Present at The 2022 LD Micro Main Event October 25-27
newsfilecorp.com · Oct 20
Bloomios to Present at the 2022 LD Micro Invitational June 7-9
prnewswire.com · May 25
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.